Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cataract-intellectual disability-anal atresia-urinary defects syndrome is characterized by congenital cataracts with squint, intellectual deficit, anomalies of the genitourinary tract (rectovesical fistula, micropenis, undescended testis, and hypospadias), imperforate anus and other anomalies.
Biomarker and diagnostic research for cataract-intellectual disability-anal atresia-urinary defects syndrome has been reported in the published literature.
No clinical trials have been registered for cataract-intellectual disability-anal atresia-urinary defects syndrome.
282 publications have been identified in PubMed for cataract-intellectual disability-anal atresia-urinary defects syndrome. Kisho has analyzed 105 by research type. Research spans Review / Meta-Analysis (59%), Basic Science / Preclinical (17%), and Case Report / Case Series (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 62 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:35 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 18 | 17% |
Patient case studies | 15 | 14% |
Disease patterns and progression | 8 | 8% |
Testing and diagnosis research | 2 | 2% |
Levergood NR (2026). [PMID: 41411089](https://pubmed.ncbi.nlm.nih.gov/41411089/). *J Neuroophthalmol*. [Epidemiology / Natural History]
Tana C (2026). [PMID: 41980458](https://pubmed.ncbi.nlm.nih.gov/41980458/). *J Fr Ophtalmol*. [Review / Meta-Analysis]
Hafsi W (2026). [PMID: 30252254](https://pubmed.ncbi.nlm.nih.gov/30252254/). *Unknown Journal*. [Basic Science / Preclinical]
Tripathi M (2026). [PMID: 36256770](https://pubmed.ncbi.nlm.nih.gov/36256770/). *Unknown Journal*. [Review / Meta-Analysis]
Xu X (2026). [PMID: 42138082](https://pubmed.ncbi.nlm.nih.gov/42138082/). *J Clin Invest*. [Basic Science / Preclinical]
Richert Q (2026). [PMID: 41619932](https://pubmed.ncbi.nlm.nih.gov/41619932/). *Chest*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Epidemiology / Natural History]
Diallo M (2025). [PMID: 41314540](https://pubmed.ncbi.nlm.nih.gov/41314540/). *Presse Med*. [Basic Science / Preclinical]
Devlin LA (2025). [PMID: 40254346](https://pubmed.ncbi.nlm.nih.gov/40254346/). *Curr Top Dev Biol*. [Review / Meta-Analysis]
Di Majo BE (2025). [PMID: 40692796](https://pubmed.ncbi.nlm.nih.gov/40692796/). *Front Immunol*. [Epidemiology / Natural History]